ஒரேன் ஆஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒரேன் ஆஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒரேன் ஆஸ் Today - Breaking & Trending Today

Nuvo Group Receives 510(k) FDA Clearance for Remote Monitoring of Uterine Activity


Nuvo Group Receives 510(k) FDA Clearance for Remote Monitoring of Uterine Activity
USA - English
News provided by
Share this article
Share this article
TEL AVIV, Israel, June 10, 2021 /PRNewswire/ Nuvo Group a private company commercializing INVU by Nuvo™, an FDA-cleared, patent-protected, prescription-initiated remote pregnancy monitoring platform today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to add a new uterine activity module that provides capability for remote monitoring of uterine activity (UA). With this clearance, INVU can provide a reliable, passive alternative to existing methods of UA measurement. INVU uses only external sensors, allowing it to be used without any invasive component or the need for an in-hospital or in-clinic procedure. ....

Joshua Copel , Oren Oz , Nuvo Group , Yale School Of Medicine , Yale School , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , New Products Amp Services , Fda Approval , Quity Amp Inclusion , ஒரேன் ஆஸ் , நூவோ குழு , யேல் பள்ளி ஆஃப் மருந்து , யேல் பள்ளி , ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் , மருத்துவ மருந்துகள் , புதியது ப்ராடக்ட்ஸ் ஆம்ப் சேவைகள் ,

Nuvo Group Submits 510(k) to Federal Drug Administration for Remote Monitoring of Maternal Uterine Activity


Nuvo Group Submits 510(k) to Federal Drug Administration for Remote Monitoring of Maternal Uterine Activity
USA - English
News provided by
Share this article
Share this article
TEL AVIV, Israel, Jan. 13, 2021 /PRNewswire/  Nuvo Group a private company commercializing INVU by Nuvo™, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform today announced that it has filed a 510(k) notice with the U.S. Food and Drug Administration (FDA) to add a new uterine activity module that provides capability for remote monitoring of maternal uterine activity (MUA). INVU has already received FDA clearance for remote monitoring and measurement of fetal and maternal heart rates. ....

United States , Oren Oz , Kristen Pessalano , Nuvo Group , Nuvo Group America , Drug Administration , ஒன்றுபட்டது மாநிலங்களில் , ஒரேன் ஆஸ் , நூவோ குழு , நூவோ குழு அமெரிக்கா ,